{{Rsnum
|rsid=9518307
|Gene=NALCN
|Chromosome=13
|position=101101810
|Orientation=plus
|GMAF=0.05326
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NALCN
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 14.2 | 85.8
| HCB | 1.5 | 13.1 | 85.4
| JPT | 0.0 | 10.7 | 89.3
| YRI | 0.0 | 13.7 | 86.3
| ASW | 0.0 | 24.6 | 75.4
| CHB | 1.5 | 13.1 | 85.4
| CHD | 0.9 | 6.5 | 92.6
| GIH | 0.0 | 19.8 | 80.2
| LWK | 0.0 | 6.4 | 93.6
| MEX | 0.0 | 10.3 | 89.7
| MKK | 0.0 | 7.1 | 92.9
| TSI | 0.0 | 10.8 | 89.2
| HapMapRevision=28
}}Unpublished article included as reference in [http://www.bibliotecadigital.ufmg.br/dspace/bitstream/1843/SMOC-7PBJQM/1/tese_renan_pedra_de_souza.pdf Farmacogenética da esquizofrenia] claims association with [[Tardive Dyskinesia]].

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}